You are here

  • Home
  • Archive
  • Volume 10, Issue 2
  • Real-world use of once-weekly semaglutide in patients with type 2 diabetes: pooled analysis of data from four SURE studies by baseline characteristic subgroups

Article metrics

Article menu
Clinical care/Education/Nutrition
Real-world use of once-weekly semaglutide in patients with type 2 diabetes: pooled analysis of data from four SURE studies by baseline characteristic subgroups

 

Online download statistics by month:

Online download statistics by month: April 2022 to March 2024

AbstractFullPdf
Apr 2022723728268
May 2022268274123
Jun 2022214213134
Jul 202217316252
Aug 202217517163
Sep 202218318253
Oct 202219018462
Nov 202222321864
Dec 202223423623
Jan 202333032458
Feb 202324824387
Mar 202323722998
Apr 202318218588
May 202321020385
Jul 202324023781
Aug 202318918562
Sep 202318217154
Oct 202321318457
Nov 2023262153105
Dec 202317113179
Jan 202437512378
Feb 202427310759
Mar 2024505202148
Total600050451981